Monitoring & surveillance of vascular access

34
MONITORING & SURVEILLANCE FOR VASCULAR ACCESS DR.GAURAV SAGAR CONSULTANT NEPHROLOGIST INDRAPRASTHA APOLLO HOSPITAL

description

Dr. Gaurav Sagar expained monitoring and sureveillance of vascular access.

Transcript of Monitoring & surveillance of vascular access

Page 1: Monitoring & surveillance of vascular access

MONITORING & SURVEILLANCE FOR VASCULAR ACCESS

DR.GAURAV SAGARCONSULTANT NEPHROLOGIST

INDRAPRASTHA APOLLO HOSPITAL

Page 2: Monitoring & surveillance of vascular access

WHAT IS MONITORING & SURVEILLANCE

• Monitoring—the examination and evaluation of the vascular access by means of physical examination to detect physical signs that suggest the presence of dysfunction.

• Surveillance—the periodic evaluation of the vascular access by using tests that may involve special instrumentation and for which an abnormal test result suggests the presence of dysfunction

Page 3: Monitoring & surveillance of vascular access

WHY SURVEILLANCE• Vascular access is the “lifeline” of a patient on

dialysis.• Low Blood flow rates and loss of patency limit

adequate dialysis dose delivery.• 0.1% decrease in Kt/V is significantly associated with

11% more increase in hospitalizations. Am J Kidney Dis 23:661–669, 1994

• Vascular access related complications accounted for 15-25% of all admissions in CKD patients . Am J Kidney Dis 37:1223–1231, 2001

• Thrombosis increases health care spending and effects QOL

Page 4: Monitoring & surveillance of vascular access

CLINICAL MONITORING

• Physical examination • A good fistula has a continuous thrill, is

compressible and is not pulsatile.• A fistula collapses when the arm is elevated,

failure of the fistula to collapse suggests outflow stenosis.

• Absent thrill, discontinuous bruit, edema distal to the fistula and aneurysmal proportion of the vein suggest access dysfunction.

Page 5: Monitoring & surveillance of vascular access

“Worm Hand “

• Presence of collaterals usually indicate outflow stenosis/obstruction

Page 6: Monitoring & surveillance of vascular access
Page 7: Monitoring & surveillance of vascular access
Page 8: Monitoring & surveillance of vascular access

CLINICAL MONITORING

• AUGMENTATION TEST• On compressing the outflow segment of AVF

the thrill is reduced and it becomes pulsatile. If there is no augmentation of the pulse it suggests inflow stenosis which may be the reason for intervention in as high as 1/3rd of cases.

Page 9: Monitoring & surveillance of vascular access

CLINICAL MONITORING• ACCESSORY VEINS• If on occluding the outflow a thrill persists it suggests presence of

accessory veins which may be an important cause of primary non maturation of AVF.

• A juxta-anastomotic venous stenosis is characterized by presence of a water hammer pulse which disappears abruptly as the stenosis is encountered.

• Presence of pseudoaneurysms is commoner than true aneuryms and indicates improper hemostasis.

• Cannulating an access to assess for flow is unacceptable.

Page 10: Monitoring & surveillance of vascular access

CLINICAL MONITORING• Problems during dialysis sessions difficulty in

cannulation, aspiration of clots, inability to reach target blood flow and prolonged bleeding from needle puncture sites.

• Unexplained more than 0.2 decrease in Kt/V on a constant dialysis prescription also suggests access dysfunction.

Page 11: Monitoring & surveillance of vascular access

CLINICAL MONITORING• Disadvantages

i. Not reproducible and requires motivation.

ii. Considered less accurate for fistulas than grafts in stenosis, partly explained by decrease frequency of stenosis in fistula.

iii. One study evaluated 543 fistulograms in 358 grafts and 185 fistulas. The positive predictive value for greater than 50 percent stenosis ( functionally significant) was only 39 percent for fistulas, as compared with 69 percent for grafts. Am J Kidney Dis 2004; 44:859

Page 12: Monitoring & surveillance of vascular access

COMPARISION OF PHYSICAL EXAMINATION& ANGIOGRAPHY

• 142 patients with access dysfunction.• Complete physical examination done by an interventional

Nephrologist.• Included inspection, palpation, auscultation augmentation

and arm elevation• Antegrade and retrograde angiography from feeding artery

to rt atrium.• Stenosis defined as luminal narrowing > 50%.• Both sets of results reviewed by an independent reviewer.• Cohens Κ used as measure of level of agreement.• 121 sets of data analysed.• - Arif et al (2007), Clin J Am Soc Neph 2: 1191 -94

Page 13: Monitoring & surveillance of vascular access

COMPARISION OF PHYSICAL EXAMINATION& ANGIOGRAPHY

Diagnosis Prevalence Sensitivity Specificity PPV NPV

Inflow stenosis

0.64 0.85 0.71 0.84 0.72

Outflow stenosis

0.61 0.92 0.86 0.91 0.87

Coexisting inflow and Outflow stenosis

0.31 0.68 0.84 0.65 0.85

Central vein stenosis

0.23 0.13 0.99 0.80 0.80

Body stenosis

0.10 0.40 0.84 0.23 0.92

- Arif et al (2007), Clin J Am Soc Neph 2: 1191 -94

Page 14: Monitoring & surveillance of vascular access

CLINICAL MONITORING

• No substitute to good physical examination and above all is free of cost.

Page 15: Monitoring & surveillance of vascular access

METHODS OF SURVEILLANCE

• 3 major types of access surveillance are: 1) Intra access blood flow monitoring 2) Static dialysis venous pressure 3) Duplex Ultrasound

Page 16: Monitoring & surveillance of vascular access

ACCESS FLOW

• QA = P/R

QA = Driving force for access flow P= Pressure Gradient between the artery and the central veins

R= Resistance in Access

Page 17: Monitoring & surveillance of vascular access

INTRA ACCESS BLOOD FLOW MONITORING

• Duplex Doppler Ultrasound (Quantitative colour velocity imaging)

• MRA• Variable Flow Doppler Ultrasound (Specs USA)• Ultrasound Dilution Technique• Critline 3 direct transcutaneous (Hema-metrics)• Glucose Pump infusion technique• Urea Dilution technique• Differential Conductivity( GAMBRO)• In Line Dialysance ( FRESENIUS)

Page 18: Monitoring & surveillance of vascular access

DILUTION METHODS FOR DIRECT FLOW MEASUREMENTS

• Principle:- temporary reversal of blood flow lines, forces obligatory recirculation through the access.

• Percentage of Recirculation depends on the ratio of blood pump speed to access flow rate.

• Access flow rate can be algebraically calculated from percentage recirculation and blood pump rate.

• Sensor placed on the downstream line to detect hematocrit, conductivity, USG pulse or temperature.

• A pertubation induced in the upstream blood line and detected downstream depends on the ratio of blood pump to access flow rate.

Page 19: Monitoring & surveillance of vascular access

HEMATOCRIT DILUTION TECHNIQUE FOR ACCESS FLOW

• Baseline sample drawn for Hct from the arterial needle after priming circuit (Ha)• Arterial and venous needles connected in a reverse direction.• Blood pump set at 300 ml/min and UF at 0.• After 12 seconds of infusing saline into the arterial needle, a 2nd sample (Hv) is

dawn from the venous needle• Saline infusion rate Qs = [1-(Qb -200)/2000] X Qb• By normal dilution balance• Qa.Ha = (Qa + Qs).Hv• = Qa.Hv + Qs.Hv• Qa.(Ha – Hv) = Qs.Hv OR• Qa = Qs.Hv• Ha – Hv• Where Qa = access blood flow

• Validated in 30 subjects with 2 consecutive readings.• Gold standard - Ultrasound dilution technique• -Tirannathanagul (2008), KI; 73: 1082 -- 1086

Page 20: Monitoring & surveillance of vascular access

HEMATOCRIT DILUTION TECHNIQUE FOR ACCESS FLOW

Y = 0.92x + 8.11N = 30R = 0.91

Hematocrit Dilution technique

US

G d

ilutio

n te

chni

que

-Tirannathanagul (2008), KI; 73: 1082 -- 1086

Page 21: Monitoring & surveillance of vascular access

ULTRASOUND DILUTION TECHNIQUE

• UDT (transonic) is amongst the most commonly used.

• Cold saline is injected in dialysis needle after reversing the lines and a sensor measures rate of change in temperature.

• Access flow is measured from the induced recirculation, the software calculates the AUC as measure of recirculation. { QA= QBP(1/R-1) }

• QBP= Blood pump flow• R= Degree of recirculation induced.

Page 22: Monitoring & surveillance of vascular access

ACCESS FLOW• Duplex Doppler Ultrasound• Requires accurate measurement of cross sectional

diameter of access, operator dependent and subject to error caused by angle of insonation

• Provides anatomic assessment• Costly• Inability to make measurements during HD

Page 23: Monitoring & surveillance of vascular access

ACCESS FLOW

• Duplex ultrasonography measures the peak systolic velocity (PSV) on either side of an area of visual stenosis.

• A PSV ratio greater than two is suspicious for significant stenosis.

Page 24: Monitoring & surveillance of vascular access

ACCESS FLOW PROTOCOL SURVEILLANCE

• Access flow should be measured monthly.• Assessment should be done in the first 1.5 hrs of

dialysis to eliminate errors caused by decrease in cardiac output or ultrafiltration.

• If access flow is < 600ml/min in a graft or < 500ml/min in a fistula patient should be referred for a fistulogram

• If access flow 1000ml/min decreases by more than 25% over 4 months patient should be referred for a fistulogram

Page 25: Monitoring & surveillance of vascular access

STATIC INTRA ACCESS PRESSURE SURVEILLANCE

• Establish a baseline and follow with trend analysis.• Calibration of pressure transducers within +/-

5mmHg.• Measure MAP in contra lateral arm.• Stop blood pump & clamp venous line proximal to

venous drip chamber, on the arterial line the occlusive roller pump serves as a clamp.

• Wait for 30s until venous pressure is stable and then record venous and arterial IAP

Page 26: Monitoring & surveillance of vascular access

STATIC INTRA ACCESS PRESSURE SURVEILLANCE

• Determine height correction h between the access and the drip chamber.

• Offset in mm Hg= 3.6+0.35x• Static IAP ratios by formula• Arterial ratio= (arterial IAP+ Ht.Correction)/ MAP• Venous ratio= (venous IAP + Ht.Correction)/ MAP

Page 27: Monitoring & surveillance of vascular access

STATIC INTRA ACCESS PRESSURE SURVEILLANCE

• The above method is tedious, time consuming and not very “user friendly”.

• There are sophisticated electronic transducers or a device consisting of a hydrophobic Luer Lok which can be connected to an aneroid manometer

Page 28: Monitoring & surveillance of vascular access

WHEN TO REFER

• In grafts static venous pressure ratios more than 0.5 and arterial ratio more than 0.75

• In fistulas static venous pressure ratios more than 0.34 and arterial ratio more than 0.43

• In central stenosis with good collateral circulation especially in AVF’s the pressures may be “normal” and these are the situations where clinical exam. Is of utmost importance

Page 29: Monitoring & surveillance of vascular access

KDOQI GUIDELINES• 4.1 Physical examination (monitoring): Physical examination to detect dysfunction in fistulae and grafts at

least monthly by a qualified individual. (B)

• 4.2 Surveillance of grafts:• 4.2.1 Preferred: 4.2.1.1 Intra-access flow. (A) 4.2.1.2 Directly measured or derived static venous dialysis pressure.

(A) 4.2.1.3 Duplex ultrasound. (A)• 4.2.2 Acceptable: 4.2.2.1 Physical examination(B)• 4.2.3 Unacceptable: 4.2.3.1 Unstandardized dynamic venous pressures (DVPs) should not

be used. (A)

Page 30: Monitoring & surveillance of vascular access

KDOQI GUIDELINES• 4.3 Surveillance in fistulae: 4.3.1 Preferred:• 4.3.1.1 Direct flow measurements. (A) 4.3.1.2 Physical examination(B) 4.3.1.3 Duplex ultrasound. (A)• 4.3.2 Acceptable: 4.3.2.1 Recirculation using a non–urea-based

dilutional method.(B) 4.3.2.2 Static pressures (B), direct or derived. (B)

Page 31: Monitoring & surveillance of vascular access

PITFALLS OF SURVEILLANCE• Observational studies showed improvement in graft

thrombosis with surveillance.• In a Meta-analysis of six randomized trials comparing

graft surveillance to clinical monitoring on graft outcome, 5 out of 6 showed no improvement in graft thrombosis. Kidney Int. 2005;67(4):1554-8, J Am Soc Nephrol. 2003;14(10):2645-53.

• Current published evidence suggests surveillance with pre-emptive angioplasty did not improve graft thrombosis or longevity.

• Conflicting results may be due to high incidence of restenosis, and probably due to advantages of intervention in newer grafts only.

Page 32: Monitoring & surveillance of vascular access

PITFALLS OF SURVEILLANCE

• In contrast to grafts in fistulas the role of QA surveillance appears to be more established.

• Larger randomized trials would be required to confirm whether surveillance techniques would improve longevity of vascular access.

Page 33: Monitoring & surveillance of vascular access

TO END

• Whether surveillance can prolong access survival is unproven.

• However it fosters the ability to salvage vascular access sites through planning, rather than urgent procedures or replacement which is an important consideration for both physicians as well as patients.

Page 34: Monitoring & surveillance of vascular access

THANK YOU FOR YOUR KIND ATTENTION